Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-64
SponsorBeijing Tiantan Hospital
About this trial
To compare the dosage requirement of etomidate under intravenous anesthesia between patients with insomnia and those with normal sleep pattern.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age of 18 - 64 years;
American Society of Anesthesiologists (ASA) physical status of I - II;
Body mass index (BMI) of 15 - 30;
Patients undergoing elective thoracoscopy, laparoscopy, hysteroscopy, open abdominal surgery, open thoracic surgery, open spinal surgery, craniotomy surgery, and digestive endoscopy under general anesthesia;
Disqualifiers
Associated with any neurological disease;
Daily alcohol consumption;
Any contraindication to intravenous anesthetic drug, such as hypotension or shock;
History of allergy to any drug used in the study;
Trial population
Patients with insomnia and patients with normal sleep patterns
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No interventions, it is a observational study
Other interventionNo interventions, this study is to compare the dosage requirement of etomidate under intravenous anesthesia between insomnia group and normal sleep group.
Treatment groups
840 Participants
are divided into 2 treatment groupsGroup A: Insomnia group1 intervention
Group B: Normal sleep group1 intervention
Trial outcomes
Primary outcomes
1
The total consumption of etomidate
The total consumption of etomidate for the entire procedure. It includes the total amount of ciprofol required by the patient for the entire procedure.
Time frame
Up to 1 daySecondary outcomes
1
The dosage of etomidate for induction
The dosage of etomidate for induction
Time frame
1 day2
The occurrence of the respiratory and cardiovascular adverse events
The occurrence of the respiratory and cardiovascular adverse events such as hypoxemia, hypotension, hypertension, arrhythmia
Time frame
The day of the procedure and 24 hours after the procedure3
The occurrence of the other adverse events
The occurrence of the other adverse events such as dizziness, agitation, nausea, vomiting and psychiatric symptom
Time frame
The day of the procedure and 24 hours after the procedure4
The incidence of intraoperative recall or awareness
The patient is conscious after anesthesia
Time frame
The day of the procedure and 24 hours after the procedureSponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Tiantan Hospital
Lead sponsor
Daxing Teaching Hospital, Capital Medical University
Collaborator
Hebei Medical University Third Hospital
Collaborator
Hengshui People's Hospital
Collaborator
Source ClinicalTrials.gov